OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship
Jiao Li, Min Sun, Xiaodong Cui, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10020-10020
Open Access | Times Cited: 40

Showing 26-50 of 40 citing articles:

The Citrus flavanone naringenin prolongs the lifespan in C. elegans and slows signs of brain aging in mice
Eugenia Piragine, Martina De Felice, Lorenzo Germelli, et al.
Experimental Gerontology (2024) Vol. 194, pp. 112495-112495
Open Access | Times Cited: 2

The Effect of Ethanol Extract from Mesua ferrea Linn Flower on Alzheimer’s Disease and Its Underlying Mechanism
Kusawadee Plekratoke, Chantana Boonyarat, Orawan Monthakantirat, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 4063-4079
Open Access | Times Cited: 5

Quercetin-1,2,3-Triazole Hybrids as Multifunctional Anti-Alzheimer’s Agents
Elisabete P. Carreiro, Ana Rodrigues Costa, Célia M. Antunes, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7495-7495
Open Access | Times Cited: 5

Anti-viral Effects of Pavetta indica Methanolic Extract and Acyclovir on Behavioral and Biochemical Parameters in Streptozotocin-induced Alzheimer's Disease in Rats
Deepak Kumar, Govind Singh, Tarun, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 13, pp. 1558-1571
Closed Access | Times Cited: 1

Uncovering potential neuroprotective flavonoids for Alzheimer's disease using cutting-edge molecular simulation and in vitro SHSY-5Y analysis
Fadilah Fadilah, Immanuelle Kezia, Linda Erlina
Journal of Pharmacy & Pharmacognosy Research (2023) Vol. 12, Iss. 2, pp. 204-217
Open Access | Times Cited: 3

Chromenone: An emerging scaffold in anti-Alzheimer drug discovery
Uma Agarwal, Saroj Verma, Rajiv Kumar Tonk
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 111, pp. 129912-129912
Closed Access

Naringenin as a potent anti-amyloidogenic polyphenol against a-synuclein aggregation: a computational approach
Mohamed J. Saadh, Zahraa Sabah Ghnim, Morug Salih Mahdi, et al.
The European Physical Journal Plus (2024) Vol. 139, Iss. 12
Closed Access

Functional ingredients of Folium Nelumbinis against amyloid-β toxicity in C. elegans: The bioactive compounds screened and the molecular mechanism explored
WenFeng Shi, Zheng Haoxue, Jing Ming, et al.
Journal of Functional Foods (2023) Vol. 109, pp. 105798-105798
Open Access | Times Cited: 1

Multi-Target Actions of Flavonoid Derivatives from Mesua ferrea Linn Flower against Alzheimer’s disease Pathogenesis
Kusawadee Plekratoke, Pornthip Waiwut, Chavi Yenjai, et al.
Biomedical Sciences and Clinical Medicine (2023) Vol. 62, Iss. 4, pp. 169-180
Open Access | Times Cited: 1

Computational Modeling of DYRK1A Inhibitors as Potential Anti-Alzheimer Agents
Eva Serrano‐Candelas, Laureano E. Carpio, Rafael Gozalbes
Neuromethods (2023), pp. 295-324
Closed Access

Systems pharmacology and multi-scale mechanism of Enicostema axillare bioactives in treating Alzheimer disease
Madhana Vigneshwari Gopal Samy, Sasidharan Perumal
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 575-593
Closed Access

Previous Page - Page 2

Scroll to top